Trials / Conditions / Prevention of Thromboembolic Events
Prevention of Thromboembolic Events
4 registered clinical trials studyying Prevention of Thromboembolic Events.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Pati NCT05471830 | Bayer | — |
| Completed | A Study to Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How NCT05419635 | Bayer | Phase 1 |
| Completed | Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney NCT04523220 | Bayer | Phase 2 |
| Completed | Study to Assess the Safety, Tolerability, Effects on the Body, Absorption, Distribution and Elimination of 25 NCT04510987 | Bayer | Phase 1 |